Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests. It’s good news, but it comes nearly two decades after the
This article looks at the different types of mucous cyst, their causes, and how they can be treated. Types of mucous cyst There are two main types of mucous cysts that this article looks at: Oral mucous cysts Oral mucous cysts develop in the mouth. They appear near salivary gland openings, often on the lips
Researchers in Germany have discovered that colon cancers are often resistant to existing drug treatments because they are composed of two different cell types that can replace each other when one cell type is killed. The study, which will be published May 16 in the Journal of Experimental Medicine, suggests that combination therapies targeting both
Within a matter of weeks, three cases of gonorrhea that are resistant to the recommended first-line antibiotic treatment have been detected in Europe and Australia. At a time with limited alternatives to the current dual therapy, lack of a vaccine and insufficient surveillance capacity in some regions, these cases highlight the growing threat of drug-resistance—which
Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition. People with cancer have an increased risk of developing blood clots, with roughly one in five experiencing venous thromboembolism (VTE) – either deep vein thrombosis (DVT) or pulmonary embolism (PE). Blood clots
A new study published today has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy. Led by Professor Catharine West, The University of Manchester team created a method of selecting prostate cancer patients who would benefit from treatments which target oxygen deficient tumours. The
A new study from the Center for Disease Dynamics, Economics & Policy (CDDEP), with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common drug resistant bacteria in the US—methicillin-resistant Staphylococcus aureus, known as MRSA—are no more expensive to treat than MSSA, the
Baking soda, also called sodium bicarbonate, is a kitchen staple commonly used as a raising agent for cakes. That being said, it has also made a name for itself as a home remedy for various conditions. Half a teaspoon of baking soda is often taken to ease heartburn or acid reflux, for example, and this
Recent advances in scientific understanding of how posttraumatic stress disorder (PTSD) develops and persists may lead to more effective treatment and even prevention of this debilitating disorder, according to the May/June special issue of Harvard Review of Psychiatry. A growing body of evidence helps psychiatrists to understand the aspects of brain structure and function involved
Researchers from the Novo Nordisk Foundation Center for Protein Research at the Faculty of Health and Medical Sciences have characterised a new protein that is important to the genetic stability of cells. It may be significant for the development of new drugs against genetically determined diseases like cancer, sterility and premature ageing. All cell nuclei
The public alcohol and drug system is chronically underfunded. About 200,000 people receive treatment for alcohol or other drug problems each year in Australia, but the demand is estimated at closer to 500,000. The result is long waiting lists for some publicly funded treatment, or people choosing private services to fill the gap. But there
It’s a discovery more than seven years in the making that researchers believe will vastly illuminate our understanding of deadly brain tumors. Gliomas are the most common type of central nervous system cancer but how these tumors develop is not fully understood. Sheri Holmen, PhD a researcher at Huntsman Cancer Institute (HCI) and professor of
Cancer patients are commonly treated with the maximum dose they are able to withstand that does not cause too many toxic side effects. However, many patients become resistant to these treatments and develop cancer recurrence. Researchers at Moffitt Cancer Center are using mathematical modeling based on evolutionary principals to show that adaptive drug treatments based
Eczema is the most common skin disease worldwide. People suffering from it often deal with a lifetime of painful symptoms. A new clinical trial is testing a natural treatment that researchers hope will provide a long-term solution for those dealing with the dry, itchy and painful skin that comes with chronic eczema. The trial uses
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published April 27 in the Journal of Experimental Medicine, suggests that a drug already approved to treat multiple sclerosis could mitigate this effect, allowing
If there is one thing all cancers have in common, it is they have nothing in common. A multi-center study led by The University of Texas MD Anderson Cancer Center has shed light on why proteins, the seedlings that serve as the incubator for many cancers, can vary from cancer to cancer and even patient
NHS set to offer cancer patients a ‘game changer’ treatment that could save THOUSANDS of lives CAR-T therapy is a new treatment for chronic lymphocytic leukaemia (CLL) The immunotherapy treatment could benefit 30,000 Britons a year Trials in the US showed it eradicated CLL in 94 per cent of patients The NHS is preparing to
Cellulitis treated with a six-day course of intravenous antibiotic flucloxacillin resulted in greater rates of relapse at 90 days post treatment despite having similar short-term results to the 12-day course, according to research presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Cellulitis, a skin infection that can become life threatening,
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life three months after treatment, but a better quality of life in the long term, compared to those on standard therapy, according to a new Northwestern Medicine study. The findings were published in the Journal of Clinical Oncology. “Treatment of prostate
A new view of a protein frequently mutated in pituitary tumors is overturning conventional wisdom and could point to novel targets for cancer drugs. The protein, a “G protein” called Gαs, initiates messages inside cells. But a single mutation alters Gαs action in a surprising way. The protein’s molecular “off switch” actually switches activity on,
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok